欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/6614/001
药品名称Bilastin STADA Arzneimittel 20 mg Tabletten
活性成分
    • bilastine 20.0 mg
剂型Tablet
上市许可持有人STADA Arzneimittel Aktiengesellschaft Stadastr. 2-18 61118 Bad Vilbel Germany
参考成员国 - 产品名称Germany (DE)
Bilastin STADA Arzneimittel 20 mg Tabletten
互认成员国 - 产品名称
    • Croatia (HR)
    • Lithuania (LT)
      Bilastine STADA 20 mg tabletės
    • Estonia (EE)
    • Slovakia (SK)
    • France (FR)
    • Luxembourg (LU)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Latvia (LV)
    • Hungary (HU)
    • Belgium (BE)
    • Bulgaria (BG)
      Bilastine Biohorn
许可日期2021/05/20
最近更新日期2024/10/02
药物ATC编码
    • R06AX29 bilastine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase